Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Mesothelioma is a rare form of chest cancer, largely caused by exposure to asbestos. The cancer usually forms in the mesothelial cells that line the lung and the chest wall. Despite current advanced technologies, mesothelioma is still a difficult-to-treat, aggressive cancer.
Stanford researchers and doctors are actively involved in developing new and better treatments for this disease, and where appropriate can offer patients access to experimental therapies through clinical trials.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.